Details of the Drug
General Information of Drug (ID: DMUSJNA)
| Drug Name |
BreMel/rGel
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
BreMel/rGel (melanoma/lobular breast cancer); Aka scFvMel/rGel (melanoma/lobular breast cancer), Targa Therapeutics; BreMel/rGel (melanoma/lobular breast cancer), Targa Therapeutics; ScFvMel/rGel (melanoma/ breast cancer), Targa Therapeutics; ScFvMel/rGel (melanoma/lobular breast cancer), Targa Therapeutics; ZME-018 antibody fragment/rGel (melanoma/ breast cancer), Targa Therapeutics
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
